Skip to Content

COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know: https://www.cancer.gov/coronavirus

Guidance for cancer researchers: https://www.cancer.gov/coronavirus-researchers

Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://www.nih.gov/coronavirus

Cancer Diagnosis Program (CDP) — Biorepositories & Biospecimen Research Branch (BBRB) Cancer Diagnosis Program (CDP) Biorepositories & Biospecimen Research Branch (BBRB)
Contact NExT
Show menu
Search this site
Last Updated: 09/01/17

BRN Symposia

Dr. Compton speaking at the BRN Symposium.

From 2009-2012 the Biospecimen Research Network (BRN) sponsored an annual research symposium to highlight the significant impact of pre-analytical biospecimen variables on cancer research and molecular medicine. The meetings featured expert presentations, interactive discussions and poster presentations from a broad range of stakeholders whose work involves biospecimens; this included researchers, clinicians, industry representatives and patient advocates.

View Highlights from Previous BRN Symposia